The present invention relates to a nutriceutical and/or pharmaceutical composition for oral use containing a calcium-containing compound.
The present invention relates to the use of sylitol as an anti-chalk acting agent in a nutriceutical and/or pharmaceutical composition for oral use containing a calcium-containing compound.
A novel omega-3 fatty acid/lipid based nutraceutical composition and a method of optimizing said omega-3 fatty acid/lipid based nutraceutical composition.
The nutraceutical is a botanical, a mineral, a mineral salt or a mixture thereof.
The present invention further concerns a nutraceutical or cosmetic preparation comprising as an active ingredient Salvia sclarea seeds, or flour, oil or pulp or extracts obtained from the seeds.
Methods for liberating a substance such as an enzyme, a pharmaceutical, or a nutraceutical from plant material are also provided.
The present invention relates to methods and systems for providing an animal with a nutraceutical program that is specifically tailored to address the deficiencies and/or needs of the particular animal.